Dominic Dwyer

Q: What Schools Are Affiliated With Dominic Dwyer

Dominic Dwyer is affiliated with the following schools: University of Kentucky, University of Sydney, University of New South Wales, University of Melbourne, University of Adelaide

Dominic Dwyer's AcademicInfluence.com Rankings

Dominic Dwyer

Biology

#6791

World Rank

#9585

Historical Rank

Virology

#241

World Rank

#248

Historical Rank

Microbiology

#606

World Rank

#674

Historical Rank

Immunology

#677

World Rank

#699

Historical Rank

biology Degrees

Download Badge

Biology

Dominic Dwyer's Degrees

Masters Microbiology University of Melbourne

Why Is Dominic Dwyer Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dominic E. Dwyer is an Australian microbiologist and Clinical Professor of Medicine for Immunology and Infectious Diseases at The University of Sydney's School of Medicine. He came from Saint Joseph's College school, that is also located at Sydney, before going to university.

(See a Problem?)

Dominic Dwyer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A cluster randomised trial of cloth masks compared with medical masks in healthcare workers (2015) (404)
Face Mask Use and Control of Respiratory Virus Transmission in Households (2009) (341)
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study (2020) (297)
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. (2009) (287)
Bed Bugs: Clinical Relevance and Control Options (2012) (272)
Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling (2020) (256)
A cluster randomized clinical trial comparing fit‐tested and non‐fit‐tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers (2011) (243)
Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets (2005) (202)
A randomized clinical trial of three options for N95 respirators and medical masks in health workers. (2013) (175)
Arboviruses associated with human disease in Australia. (2000) (163)
Influenza Virus A (H10N7) in Chickens and Poultry Abattoir Workers, Australia (2012) (163)
Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia (2012) (160)
The contrasting phylodynamics of human influenza B viruses (2015) (159)
Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 (2020) (154)
Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. (2009) (141)
Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus (2013) (138)
CME ACTIVITY: Face Mask Use and Control of Respiratory Virus Transmission in Households (2009) (132)
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia (2010) (132)
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran (2020) (131)
Rapid and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus by Rolling Circle Amplification (2005) (129)
Probable human infection with a newly described virus in the family Paramyxoviridae. The NSW Expert Group. (1998) (129)
Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. (1996) (113)
Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 (2020) (106)
A clinicopathological study of three cases of severe acute respiratory syndrome (SARS) (2003) (101)
National Serosurvey of Cytomegalovirus in Australia (2006) (99)
Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA) (2009) (99)
Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors (2004) (98)
Comparison of a Rapid Antigen Test with Nucleic Acid Testing during Cocirculation of Pandemic Influenza A/H1N1 2009 and Seasonal Influenza A/H3N2 (2009) (96)
The impact of bacterial and viral co‐infection in severe influenza (2012) (92)
Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. (1998) (90)
Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter (2010) (86)
Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011. (2014) (86)
Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers (2014) (85)
Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study (2013) (85)
Probable Psittacosis Outbreak Linked to Wild Birds (2005) (85)
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial (2019) (83)
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use (2022) (79)
Comparison of the incidence of influenza in relation to climate factors during 2000–2007 in five countries (2010) (75)
Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community (2006) (74)
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. (2011) (74)
Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study (2013) (73)
Laboratory diagnosis of human seasonal and pandemic influenza virus infection (2006) (71)
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. (2010) (71)
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions (2021) (70)
Evaluation of the Cepheid Xpert Flu Assay for Rapid Identification and Differentiation of Influenza A, Influenza A 2009 H1N1, and Influenza B Viruses (2012) (68)
HIV INFECTION OF RECTAL MUCOSA (1988) (68)
Viral exanthems (2015) (68)
Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant (2021) (66)
Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. (1993) (66)
Influenza Outbreaks during World Youth Day 2008 Mass Gathering (2010) (66)
Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease (2011) (65)
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. (2010) (64)
Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. (2005) (62)
The prevention and management of herpes zoster (2008) (61)
Detection of influenza A and B with the Alere™ i Influenza A & B: a novel isothermal nucleic acid amplification assay (2015) (60)
Outbreaks of Pandemic (H1N1) 2009 and Seasonal Influenza A (H3N2) on Cruise Ship (2010) (58)
Listeriosis — a review of eighty‐four cases (1994) (57)
The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies (2013) (57)
Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003 (2006) (57)
Epstein–Barr virus and multiple sclerosis (2011) (56)
Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic (2021) (56)
Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis (2012) (55)
Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015 (2019) (55)
Viral respiratory infections among Hajj pilgrims in 2013 (2014) (54)
Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach (2013) (53)
Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8+ T cells during HAART. (2003) (52)
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. (1998) (50)
Clinical features of endemic community-acquired psittacosis (2014) (49)
Point-of-care diagnostics for respiratory viral infections (2017) (49)
Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. (2008) (48)
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. (2011) (47)
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection (2021) (47)
LABORATORY DIAGNOSIS OF INFLUENZA VIRUS INFECTION (2002) (45)
The Antibody Response to SARS-CoV-2 Infection (2020) (45)
Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. (2013) (45)
Hepatitis C transmission and HIV post‐exposure prophylaxis after needle‐ and syringe‐sharing in Australian prisons (2003) (43)
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance (2022) (42)
HIV-1 co-infection, superinfection and recombination. (2004) (42)
The survival of influenza A(H1N1)pdm09 virus on 4 household surfaces. (2014) (42)
A comparison of hospital and community-acquired infective endocarditis. (1992) (41)
Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells (2000) (41)
Treating and Preventing Influenza in Aged Care Facilities: A Cluster Randomised Controlled Trial (2012) (41)
Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration (2018) (41)
Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification. (2009) (41)
The impact of influenza virus infection in pregnancy. (2018) (40)
Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness (2010) (40)
Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal. (2006) (40)
Influenza antiviral resistance in the Asia-Pacific region during 2011. (2013) (40)
Emerging recombinant noroviruses identified by clinical and waste water screening (2018) (39)
Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus (2004) (39)
HIV‐1 compartmentalization in diverse leukocyte populations during antiretroviral therapy (2004) (39)
Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. (2013) (38)
Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region. (2011) (38)
Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster (2008) (37)
Point‐of‐care testing for community‐acquired pneumonia: do we have all the answers? (2007) (37)
Cross‐reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians (2011) (37)
Changes in Patterns of Hospitalized Children With Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia (2013) (37)
Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling (2020) (36)
Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms. (2008) (35)
Rapid diagnosis of varicella-zoster virus infection with a monoclonal antibody based direct immunofluorescence technique. (1989) (34)
Extrapulmonary tuberculosis--a continuing problem in Australia. (1987) (34)
Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies (2014) (34)
“Operation South East Asia Tsunami Assist”: an Australian team in the Maldives (2005) (34)
Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. (2010) (34)
Declining measles antibodies in the era of elimination: Australia's experience. (2018) (33)
Knowledge, Attitude and Practice (KAP) Survey Concerning Antimicrobial Use among Australian Hajj Pilgrims. (2014) (33)
Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye (2010) (33)
A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims (2014) (32)
Segregation of Human Immunodeficiency Virus Type 1 Subtypes by Risk Factor in Australia (2003) (32)
Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. (2004) (32)
Role of human papillomaviruses in esophageal squamous cell carcinoma (2013) (32)
Viral Pneumonitis Is Increased in Obese Patients during the First Wave of Pandemic A(H1N1) 2009 Virus (2013) (31)
Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes. (1999) (31)
The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis (2020) (31)
Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network. (2014) (31)
Incompletely matched influenza vaccine still provides protection in frail elderly. (2010) (31)
Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses (2009) (30)
Current status of matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical microbiology laboratory (2013) (30)
Influenza vaccination among Australian Hajj pilgrims: uptake, attitudes, and barriers. (2014) (30)
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019 (2020) (29)
Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages (2007) (29)
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course (2014) (29)
Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1 (2007) (29)
The effectiveness of prophylaxis for measles contacts in NSW. (2009) (29)
An outbreak of epidemic keratoconjunctivitis in a regional ophthalmology clinic in New South Wales (2007) (29)
Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives. (2004) (28)
An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes. (1996) (28)
Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection (2003) (27)
Influenza Outbreak during Sydney World Youth Day 2008: The Utility of Laboratory Testing and Case Definitions on Mass Gathering Outbreak Containment (2009) (27)
Zika virus: what, where from and where to? (2017) (26)
Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. (2006) (26)
Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia (2018) (26)
Molecular diagnosis of respiratory viruses (2015) (25)
Pandemic (H1N1) 2009 Influenza Virus Seroconversion Rates in HIV-Infected Individuals (2011) (25)
The burden of influenza in children under 5 years admitted to the Children's Hospital at Westmead in the winter of 2006 (2009) (25)
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network. (2016) (24)
10: Herpes simplex and varicella–zoster virus infections (2002) (24)
An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic (2022) (24)
Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents (2009) (24)
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure (2009) (24)
A national study of the molecular epidemiology of HIV-1 in Australia 2005–2012 (2017) (24)
Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. (2007) (23)
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN). (2019) (23)
Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trial (2020) (23)
Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006. (2009) (23)
Characteristics of a Widespread Community Cluster of H 275 Y Oseltamivir-Resistant A ( H 1 N 1 ) pdm 09 In fl uenza in Australia (2012) (23)
Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam (2020) (22)
Influenza vaccination amongst hospital health care workers in Beijing. (2010) (22)
Kinetics of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibodies in 271 Laboratory-Confirmed Cases of SARS (2004) (22)
Evaluation of the Sofia Influenza A + B fluorescent immunoassay for the rapid diagnosis of influenza A and B (2015) (22)
Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism. (2000) (22)
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses (2022) (21)
Respiratory viruses transmission from children to adults within a household (2011) (21)
Feasibility Exercise to Evaluate the Use of Particulate Respirators by Emergency Department Staff During the 2007 Influenza Season (2009) (21)
A review of medical masks and respirators for use during an influenza pandemic (2009) (21)
Hospital practices influence the pattern of infective endocarditis (1994) (21)
Laboratory test performance in young adults during influenza outbreaks at World Youth Day 2008. (2009) (20)
Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales, Australia (2014) (20)
Prevalence of varicella-zoster virus genotypes in Australia characterized by high-resolution melt analysis and ORF22 gene analyses. (2010) (20)
Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN). (2013) (20)
Facemask versus No Facemask in Preventing Viral Respiratory Infections During Hajj: A Cluster Randomised Open Label Trial (2019) (19)
Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points. (2012) (19)
Origins of SARS-CoV-2: window is closing for key scientific studies (2021) (19)
Evidence of the circulation of pandemic influenza (H1N1) 2009 with D222D/G/N/S hemagglutinin polymorphisms during the first wave of the 2009 influenza pandemic. (2011) (19)
Indinavir-induced renal failure. (1998) (19)
Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose (2021) (19)
Viral Phenotypes and Antibody Responses in Long-Term Survivors Infected with Attenuated Human Immunodeficiency Virus Type 1 Containing Deletions in the nef and Long Terminal Repeat Regions (2007) (19)
ASID/TSANZ guidelines: Treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents (2009) (18)
Region-specific changes, gene duplications, and random deletions in the nef gene from HIV type 1-infected brain tissues and blood of a demented patient. (1997) (18)
HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments (2008) (18)
Identification of 20 Common Human Enterovirus Serotypes by Use of a Reverse Transcription-PCR-Based Reverse Line Blot Hybridization Assay (2009) (18)
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN). (2019) (18)
Evaluation of point-of-care testing in critically unwell patients: comparison with clinical laboratory analysers and applicability to patients with Ebolavirus infection (2015) (18)
HSV type specific serology in sexual health clinics: use, benefits, and who gets tested (2004) (18)
Hospital Health Care Workers’ Understanding of and Attitudes Toward Pandemic Influenza in Beijing (2012) (17)
The pathogenesis underlying the interaction of HIV and herpes simplex virus after co-infection. (2004) (17)
Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020 (2021) (17)
Coinfection and genetic recombination between HIV-1 strains: possible biological implications in Australia and South East Asia. (1997) (17)
Use of the 5' untranslated region and VP1 region to examine the molecular diversity in enterovirus B species. (2014) (16)
Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV) (2007) (16)
The use of oseltamivir during an influenza B outbreak in a chronic care hospital (2009) (16)
CLINICAL AND LABORATORY FEATURES OF RUBELLA (2001) (16)
Serological reaction to Legionella pneumophila group 4 in a patient with Q fever. (1988) (16)
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020 (2020) (16)
Antivirals in the management of an influenza pandemic (2006) (15)
The Burden of Infectious Gastroenteritis in Elderly Residents and Staff of Long-Term Care Facilities, Australia (2010) (15)
Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting (2021) (15)
Endocarditis associated with prosthetic cardiac valves (1990) (14)
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. (2011) (14)
Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning. (2015) (14)
Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). (2015) (14)
Point of care testing: diagnosis outside the virology laboratory. (2011) (14)
Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011. (2012) (14)
Surveillance for outbreaks of influenza-like illness in the institutionalized elderly (2009) (13)
Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys (2015) (13)
Surveillance of Australian Hajj pilgrims for carriage of potentially pathogenic bacteria: Data from two pilot studies (2017) (13)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 (2017) (13)
Outbreak of human metapneumovirus infection in a residential aged care facility. (2009) (13)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 (2017) (13)
Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore (2013) (13)
Epstein-Barr Virus Genotypes and Strains in Central Nervous System Demyelinating Disease and Epstein-Barr Virus-Related Illnesses in Australia (2012) (13)
Human coronavirus data from four clinical trials of masks and respirators (2020) (13)
Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness (2013) (12)
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2016: the Influenza Complications Alert Network (FluCAN). (2017) (12)
Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naïve HIV-1 infected individuals by rolling circle amplification. (2009) (12)
An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines. (2019) (12)
A Randomized Study of Standard versus Double dose Oseltamivir for Treating Influenza in the Community (2014) (12)
Hendra virus: a one health tale of flying foxes, horses and humans. (2013) (12)
COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control (2021) (12)
Arbovirus and vector surveillance in New South Wales, 2004/05-2007/08 (2009) (12)
Acute exercise decreases vaccine reactions following influenza vaccination among older adults (2019) (12)
Influenza: One Health in action. (2011) (12)
Sentinel Chicken Surveillance Programme in Australia, 1 July 2001 to 30 June 2002. (2002) (12)
Acute encephalitis complicating rubella virus infection. (1992) (11)
Enfuvirtide in HIV-1-Infected Individuals Changing Therapy to A Nucleoside Reverse Transcriptase Inhibitor Sparing Regimen: The Alliance Study (2005) (11)
Clinical and laboratory findings on the first imported case of Murray Valley encephalitis in Europe. (2003) (11)
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study (2017) (11)
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study (2017) (11)
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study (2017) (11)
Dementia and pancytopenia in a patient who died of AIDS within one year of primary human immunodeficiency virus infection. (1996) (11)
Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A. (2004) (11)
Diagnostic tests: Rapid tests for the diagnosis of influenza (2009) (11)
Neurocysticercosis: an under‐recognized cause of neurological problems (1990) (11)
Difficulties With The Serologic Diagnosis Of Infectious Mononucleosis: A review of the RCPA Quality Assurance Programs (1996) (10)
Comparison of three commercial assays for the quantification of plasma HIV-1 RNA from individuals with low viral loads. (1999) (10)
What assay is optimal for the diagnosis of measles virus infection? An evaluation of the performance of a measles virus real-time reverse transcriptase PCR using the Cepheid SmartCycler(®) and antigen detection by immunofluorescence. (2015) (10)
Phylogenetic analysis of human rhinoviruses collected over four successive years in Sydney, Australia (2016) (10)
Multiple Sources of Genetic Diversity of Influenza A Viruses during the Hajj (2017) (10)
Molecular Identification and Analysis of Nonserotypeable Human Enteroviruses (2010) (10)
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests (2020) (10)
Subtype B isolates of human immunodeficiency virus type 1 detected in Australia. (1996) (10)
Immunisation and multi-dose vials. (2010) (10)
Mass gatherings and the implications for the spread of infectious diseases. (2012) (10)
Australian rubella serosurvey 2012-2013: On track for elimination? (2018) (10)
Human immunodeficiency virus type 1 subtypes B and C detected in New Zealand. (1998) (9)
Virological diagnosis of Ebolavirus infection (2015) (9)
How common was 2009 pandemic influenza A H1N1? (2011) (9)
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong: accuracy amidst ambiguity. (2011) (9)
The AIDS Knowledge base, Sande Cohen, Volberding. Williams & Wilkins, Lippincott (1999), ISBN 0-316-14903-9, Hardcover, pp. xx + 966, US$269 (2000) (9)
Viral markers in HIV infection and AIDS. (1993) (9)
Detection of human immunodeficiency virus type 2 in brain tissue. (1992) (9)
A Randomized Study to Evaluate Injection Site Reactions using Three Different Enfuvirtide Delivery Mechanisms (the OPTIONS Study) (2008) (9)
Cytomegalovirus Disease Amongst Renal Transplant Recipients in Australia and New Zealand (2008) (8)
Emergence of Japanese encephalitis in Australia: a diagnostic perspective. (2022) (8)
Human pegivirus in brain tissue of a patient with encephalitis. (2019) (8)
The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection (2001) (8)
Genotyping of human adenoviruses using a PCR-based reverse line blot hybridisation assay (2011) (8)
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine (2020) (8)
Clinical Features, Oseltamivir Treatment and Outcome in Infants Aged <12 Months with Laboratory-Confirmed Influenza a in 2009 (2011) (8)
Early detection of human immunodeficiency virus type 1 infection in Australian infants at risk of perinatal infection and factors affecting transmission. (1994) (8)
Global Epidemiology of Sexually Transmitted Diseases (2013) (8)
Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers - authors' reply. (2014) (8)
Short communication: absence of HIV infection in the choroid plexus of two patients who died rapidly with HIV-associated dementia. (2008) (7)
Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example (2011) (7)
Antivirals for herpes simplex viruses (2015) (7)
First human immunodeficiency virus type 1 sequences in the V3 region, nef and vpr genes from Papua New Guinea. (1997) (7)
4 Herpes simplex virus infection in pregnancy (1993) (7)
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic (2018) (7)
A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients (2015) (7)
Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals (2013) (7)
Outbreaks of Pandemic ( H 1 N 1 ) 2009 and Seasonal Infl uenza A ( H 3 N 2 ) on Cruise Ship (2010) (7)
HIV type 1 V3 loop sequences derived from peripheral blood of transmitting mothers, their infants, and nontransmitting mothers differ in their crown octapeptide motifs. (1997) (6)
Prolonged varicella viraemia and streptococcal toxic shock syndrome following varicella vaccination of a health care worker (2009) (6)
High risk procedures and respiratory infections in hospital health care workers – quantifying the risk (2012) (6)
RESISTANCE CONFERRING MUTATIONS IN SARS-CoV-2 DELTA FOLLOWING SOTROVIMAB INFUSION (2021) (6)
Identification of infection of an Australian resident with the human immunodeficiency virus type 2 (HIV‐2) (1992) (6)
Comparing the use of, and considering the need for, lumbar puncture in children with influenza or other respiratory virus infections (2012) (6)
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey (2022) (6)
Length polymorphism of the viral protein R of human immunodeficiency virus type 1 strains. (1996) (6)
Advances in antiviral therapy (1997) (6)
Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney‐pancreas transplant recipients (2013) (6)
Influenza: overview on prevention and therapy. (2019) (6)
Significance of plasma and peripheral blood mononuclear cell derived HIV-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to HIV-1. (1999) (5)
Recent increases in the notification of Barmah Forest virus infections in New South Wales. (2004) (5)
Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, Australia (2022) (5)
Herpes simplex encephalitis in infants (1986) (5)
An outbreak of typhoid associated with a “iafet” in Vanuatu (1995) (5)
High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma—Letter (2011) (5)
Challenges for the laboratory before and during an influenza pandemic. (2006) (5)
Managing outbreaks of viral respiratory infection in aged care facilities — challenges and difficulties during the first pandemic wave (2010) (5)
Health care worker practices around face mask use in hospitals in Hanoi, Vietnam (2012) (5)
The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia (2020) (5)
An Amplicon-Based Approach for the Whole-Genome Sequencing of Human Metapneumovirus (2021) (5)
Simultaneous co-detection of wild-type and vaccine strain measles virus using the BD MAX system. (2018) (5)
Subtype‐specific differences in transmission cluster dynamics of HIV‐1 B and CRF01_AE in New South Wales, Australia (2021) (4)
Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia (2021) (4)
HIV Recombination and Pathogenesis – Biological and Epidemiological Implications (2011) (4)
Avian influenza and planning for pandemics (2004) (4)
Herpes Simplex: Viruses and Infections (2009) (4)
Probable association between Barmah Forest virus infection and Gulllaln‐Barre syndrome (1998) (4)
Pneumococcal colonisation following influenza infection. (2011) (4)
Viral arthritides (2011) (4)
Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine. (2020) (4)
COVID‐19 in Australia: our national response to the first cases of SARS‐CoV‐2 infection during the early biocontainment phase (2020) (4)
The diagnosis and management of influenza. An update. (1999) (4)
Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus‐associated nephropathy in kidney recipients (2009) (4)
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy (2022) (4)
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance (2020) (4)
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes (2022) (4)
The spatial-temporal dynamics of respiratory syncytial virus infections across the east–west coasts of Australia during 2016–17 (2021) (4)
Confusion, cortical blindness and fever (1995) (4)
The Changing Epidemiology of Severe Cytomegalovirus Disease in Australia (2007) (3)
BK polyomavirus: a review of the virology, pathogenesis, clinical and laboratory features, and treatment (2017) (3)
4.3 The laboratory in managing HIV infection (1996) (3)
Molecular Evidence for Transmission of Human T-Lymphotropic Virus Type II Infection by a Human Bite (1999) (3)
The spatial-temporal dynamics of respiratory syncytial virus infections across the east-west coasts of Australia during 2016-17 (2020) (3)
Partial nucleotide sequence analysis of the first case of human T lymphotropic virus type II from Australia. (1995) (3)
Ischaemic heart disease , in fl uenza and in fl uenza vaccination : a prospective case control study (2013) (3)
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine (2022) (3)
Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia (2019) (3)
Influenza B Viruses of Influenza A, Influenza A 2009 H1N1, and for Rapid Identification and Differentiation Evaluation of the Cepheid Xpert Flu Assay (2012) (3)
SARS-CoV-2 Genome Sequencing Methods Differ In Their Ability To Detect Variants From Low Viral Load Samples (2021) (3)
Pre-treatment Antiviral Resistance in Australians with Chronic Hepatitis C: Prevalence of NS3 and NS5A Resistance Data in the State of New South Wales (2019) (3)
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting (2021) (3)
An international survey of bacterial contamination and householders’ knowledge, attitudes and perceptions of hygiene (2013) (3)
Herpes simplex virus infection in pregnancy. (1993) (2)
Australian mumps serosurvey 2012-2013: any cause for concern? (2020) (2)
Advances in HIV laboratory testing. (2010) (2)
Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales, Australia (2014) (2)
Evolution of HIV-1 surveillance drug resistance mutations over ten years in New South Wales, Australia. (2017) (2)
Managing HIV. Part 3: Mechanisms of disease. 3.1 Structure and function of HIV. (1996) (2)
3.1 Structure and function of HIV (1996) (2)
HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia (2018) (2)
Australasian Society for Infectious Diseases 2015 conference report: one health, one world (2015) (2)
Editorial: Laboratory preparedness for Ebolavirus disease. (2015) (2)
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia (2010) (2)
Anaesthesia and Emerging Infectious Diseases (1996) (2)
The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2 (2023) (2)
Linear normalised hash function for clustering gene sequences and identifying reference sequences from multiple sequence alignments (2012) (2)
Molecular Analysis of Enterovirus C Species Using the 5’ Untranslated Region and VP1 Region (2015) (2)
The Perils of Promiscuity (1988) (2)
Prolonged PCR positivity in elderly patients infected with SARS-CoV-2 (2021) (2)
The Burden of Pertussis in Patients with and without Recurrent Ischaemic Vascular Events. (2014) (1)
New Detection of Locally Acquired Japanese Encephalitis Virus Using Clinical Metagenomics, New South Wales, Australia (2023) (1)
Reduction in Hospitalisation for Cytomegalovirus Disease in HIV-Infected Patients Before and After the Introduction of Highly Active Antiretroviral Therapy (2008) (1)
HIV Post exposure prophylaxis in the prison setting (2001) (1)
Complete Genome Sequences, Derived by Next-Generation Sequencing, of JC Polyomavirus Strains Isolated from Vietnamese Renal Transplant Recipients (2020) (1)
Active surveillance and point-of-care testing (POCT) allows early intervention for influenza outbreaks in nursing homes (NHs). (2007) (1)
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomised controlled trial. (2020) (1)
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). (2022) (1)
Rapid on‐site molecular Point of Care Testing during influenza outbreaks in aged care facilities improves antiviral use and reduces hospitalisation (2022) (1)
Guiding the design of SARS-CoV-2 genomic surveillance by estimating the resolution of outbreak detection (2022) (1)
Evaluation of the FluA-Ag rapid assay for detection of influenza A viruses of human, avian, and swine origin. (2014) (1)
Lessons from the NSW laboratory response to pandemic (H1N1) 2009 influenza. (2010) (1)
Changes in HIV‐1 viral load trends with highly active antiretroviral therapy (2001) (1)
Seasonal, avian and pandemic influenza viruses (2008) (1)
SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers (2021) (1)
Molecular Analysis of Enteroviruses (2016) (1)
PCR amplification of large genomic fragments from human and simian immunodeficiency virus infected cell lines. (1992) (1)
Increased HIV Subtype Diversity Reflecting Demographic Changes in the HIV Epidemic in New South Wales, Australia (2020) (1)
Seroprevalence of Pandemic (H1N1) 2009 Influenza in HIV-infected Individuals (2010) (1)
Advances and controversies in the antiviral therapy of herpes zoster (1996) (1)
Outbreak of viral respiratory infections in an aged care facility in NSW - lessons about a pandemic virus (2011) (1)
Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses (2021) (1)
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). (2022) (1)
of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 (2020) (1)
Long-term persistence of neutralizing memory B cells in SARS-CoV-2 (2020) (1)
Shingles vaccine. Is it worth the effort (2013) (0)
The role of human papillomaviruses in oesophageal squamous cell carcinoma: a review of the evidence (2012) (0)
The changing serological profile of hepatitis A in Victoria, Australia: a comparison of three time points (2012) (0)
Blood-Borne Disease (2010) (0)
Arthropod-Borne Flaviviruses in Pregnancy (2023) (0)
Special Issue on HIV/AIDS: Infectious Disease Reports (2013) (0)
Zostavax for shingles (2009) (0)
Epilogue: Preparing for an influenza pandemic in Australia (2006) (0)
ENHANCED DETECTION OF MEASLES VIRUS INFECTION FOLLOWING SUCCESSFUL DEVELOPMENT OF A REAL-TIME REVERSE TRANSCRIPTASE PCR IN RESPIRATORY AND URINE SAMPLES USING THE CEPHEID SMARTCYCLER® (2015) (0)
Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the “PROTECT” phase of the pandemic response (2010) (0)
Influenza as Risk Factor for Ischaemic Cardiac Events and the Effects of Influenza Vaccination. Outcomes from a Three-Year Prospective Case–control Study Conducted in the Australian Winters of 2008–2010 (HEART-FLU Study) (2011) (0)
Quantifying the efficacy of influenza vaccines. (2012) (0)
Laboratory diagnosis of influenza and the impact of the pandemic (H1N1) 2009 virus (2011) (0)
Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity (2023) (0)
Macrophage tropism of an acutely lethal simian immunodeficieny virus, SIVsmm-PBjl4 (1992) (0)
FATAL OSELTAMIVIR-RESISTANT INFLUENZA A/ SOLOMAN ISLANDS/3/2006 (H1N1) INFECTION IN A CORD BLOOD HAEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) RECIPIENT: 2191 (2008) (0)
Outbreaks of Human Metapneumovirus in Western Sydney Aged-Care Facilities in 2018. (2022) (0)
Antivirals for treatment and prevention of human seasonal influenza (2006) (0)
Truth, double truth and statistics. (2010) (0)
A comparative study of anti retroviral drug resistance profiles in two areas of Sydney , Australia from 1986 – 2003 (2012) (0)
High Frequency of Stop Codons in the Human Immunodeficiency Virus-1 Protease Gene Frame in Human Immunodeficiency Virus+ Individuals with Below Detectable Levels of Plasma Viremia During Highly Active Antiretroviral Therapy (2012) (0)
Viral respiratory infections among Hajj pilgrims in 2013 (2014) (0)
Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection (2021) (0)
Epstein-Barr virus infection (1998) (0)
Confusion, cortical blindness and fever (1995) (0)
Comparison of influenza A(H1N1)pdm09 mortality with seasonal influenza mortality in Australia (2012) (0)
Failure to Detect Oseltamivir Resistance by RollingCircle Amplification and Sequencing Following Use in anInfluenza A (H3N2) Outbreak at an Aged Care Facility (2009) (0)
Identiﬁcation of 20 Common Human Enterovirus Serotypes by Use of a Reverse Transcription-PCR-Based Reverse Line Blot Hybridization Assay (cid:1) (2009) (0)
Practical problems and responses for SARS-CoV-2 laboratory testing during the COVID-19 pandemic (2023) (0)
NSW arbovirus surveillance web site (1999) (0)
Herpes simplex virus and varicella zoster virus infections: clinical presentations and treatment strategies (2009) (0)
Australian medicine 1997/1998 (1997) (0)
Australian encephalitis: Sentinel chicken programme (2000) (0)
The Relationship Between Seasonal Influenza Vaccine Uptake and Socioeconomic Status in Western Sydney. Substudy of the Heart-Flu Study 2008–2009 (2011) (0)
Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2 (2022) (0)
Diagnosis of influenza following the first wave of pandemic (H1N1) 2009 influenza (2010) (0)
Fabrizio Inhibitors Evolution of Viral Resistance to Protease Immunodeficiency Virus Type 1 in the Role of Minority Populations of Human (2004) (0)
Deep Sequencing of Urine Specimens Detects Two BK Polyomavirus Genotypes in a Hematopoietic Stem Cell Transplant Recipient (2020) (0)
Correction: A Randomized Study of Standard versus Double dose Oseltamivir for Treating Influenza in the Community (2018) (0)
O20.1 The challenges of diversity: hiv-1 subtype distribution and transmission networks within the australian molecular epidemiology network-hiv 2005–2012 (2015) (0)
Does influenza precipitate acute ischaemic heart disease? A prospective case control study (2012) (0)
Corrigendum to “Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers” [Prev. Med. 62 (2014) 1–7] (2014) (0)
RAPIDprep: A Simple, Fast Protocol for RNA Metagenomic Sequencing of Clinical Samples (2023) (0)
AustraliaType 1 Subtypes by Risk Factor in Segregation of Human Immunodeficiency (2014) (0)
' s response to reviews Title : Rapid semi-automated quantitative multiplex tandem PCR ( MT-PCR ) assays for the differential diagnosis of influenza-like illness (2010) (0)
OptionsBugs: Clinical Relevance and Control (2012) (0)
SARS-CoV-2 Seroprevalence in a Cohort of International Travellers Returning to Rural Australia: Enablers and Barriers to Containment of COVID-19 (2023) (0)
Human Metapneumovirus – Clinical Virology (2016) (0)
Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia (2021) (0)
Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Infl uenza 1 (2019) (0)
Fat and flu: fact or fiction? (2016) (0)
COMPARISONS OF THE SEROLOGICAL IMPACT OF A(H1N1) PDM2009 INFLUENZA IN POPULATION GROUPS OF THE SOUTHERN HEMISPHERE (2012) (0)
Abstract 18873: Undiagnosed, Unrecognised Influenza is a Risk Factor for Ischemic Vascular Events (2010) (0)
Undiagnosed, unrecognised influenza and other respiratory viruses as a risk factor for ischaemic vascular events (2009) (0)
RCPA Quality Assurance Programs Pty Ltd Presentations (2012) (0)
1 Evolution of human respiratory syncytial virus ( RSV ) 2 over multiple seasons in New South Wales , Australia 3 4 (2018) (0)
Respiratory Viral Illness in a Cohort of Children Presenting to a Children's Hospital Emergency Department (2008) (0)
Point-of-Care Tests: Pointless or Useful? (2008) (0)

This paper list is powered by the following services:

Other Resources About Dominic Dwyer

en.wikipedia.org

What Schools Are Affiliated With Dominic Dwyer?

Dominic Dwyer is affiliated with the following schools:

Dominic Dwyer's Academic­Influence.com Rankings

Dominic Dwyer's Degrees

Why Is Dominic Dwyer Influential?

Dominic Dwyer's Published Works

Published Works

Other Resources About Dominic Dwyer

What Schools Are Affiliated With Dominic Dwyer?

Dominic Dwyer's AcademicInfluence.com Rankings